Head to head
XP Inc vs Morgan Stanley
Side-by-side on the measures that matter, with a plain-English read. Full detail: XP · MS
XP
XP Inc
29.53-0.67%
1-year price shape — +84% over the period
Quant Rating B · 90/100
vs
MS
Morgan Stanley
189.71-0.69%
1-year price shape — +24% over the period
Quant Rating D · 64/100
1-year performance, rebased to 100
Morgan Stanley edges it on the scoreable measures. Morgan Stanley pays the highest dividend yield; Morgan Stanley earns the most per share.
| XP | MS | |
|---|---|---|
| Snapshot | ||
| Sector | Capital Markets | -- |
| Last price | 29.53 | 189.71 |
| Change today | -0.67% | -0.69% |
| 1-year return | +83.6% | +24.4% |
| Market cap | $14.98B | $297.95B |
| 52-week range | 14.80 – 30.22 | 148.51 – 230.98 |
| Valuation | ||
| P/E (TTM) | 14.61 | 15.32 |
| P/E percentile, own 5-yr range | 57th | 46th |
| P/B | 3.03 | 2.80 |
| Dividend yield | 1.33% | 2.11% |
| Profitability & growth | ||
| EPS (TTM) | 1.94 | 10.21 |
| Net profit (TTM) | $983.42M | $16.04B |
| Revenue (TTM) | $8.42B | $73.05B |
| Revenue growth (YoY) | +9.7% | +27.4% |
| Gross margin | 27.6% | -- |
| Operating margin | -55.6% | -- |
| Net margin | 63.1% | 26.8% |
| Free cash flow (TTM) | $12.79B | $-18.58B |
| Ownership & sentiment | ||
| Institutional ownership | 88.2% | 87.0% |
| Insider activity (12mo) | 0 buy / 2 sell | 23 buy / 27 sell |
| Short interest (% of float) | 3.5% | 0.9% |
| Analyst consensus | 80% buy / 20% hold (5) | 62% buy / 38% hold (13) |
| Analyst price target | $24 (-19%) | $241 (+27%) |
| StockVane view | ||
| StockVane Quant Rating | B (90) | D (64) |
| Company | ||
| Employees | 8,069 | 83,000 |
| Founded | 2001 | 1924 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.